EDGAR Filing Documents for 0001144204-17-026099

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001144204-17-026099

Filing Date

2017-05-10

Accepted

2017-05-10 16:46:00

Documents

Effectiveness Date

2017-05-10

Document Format Files

Seq	Description	Document	Type	Size
1	S-3ASR	v466300_s3asr.htm	S-3ASR	457923
2	EXHIBIT 4.1	v466300_ex4-1.htm	EX-4.1	330213
3	EXHIBIT 4.2	v466300_ex4-2.htm	EX-4.2	358014
4	EXHIBIT 4.3	v466300_ex4-3.htm	EX-4.3	42775
5	EXHIBIT 4.4	v466300_ex4-4.htm	EX-4.4	43936
6	EXHIBIT 5.1	v466300_ex5-1.htm	EX-5.1	36262
7	EXHIBIT 12.1	v466300_ex12-1.htm	EX-12.1	25101
8	EXHIBIT 23.1	v466300_ex23-1.htm	EX-23.1	2689
9	GRAPHIC	image_001.jpg	GRAPHIC	1654
10	GRAPHIC	image_002.jpg	GRAPHIC	7207
11	GRAPHIC	line.gif	GRAPHIC	43
12	GRAPHIC	spacer.gif	GRAPHIC	43
	Complete submission text file	0001144204-17-026099.txt		1310807

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011

Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)